LILRB1 and central nervous system cancer: Immunohistochemical staining of the 38 clinical samples confirmed a different level of LILRB1 expression in tumor tissues in different glioma grades (Fig. 3A) and the LILRB1 expression increased with rising glioma pathological grade (Fig. 3B).